Log in to save to my catalogue

Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic he...

Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic he...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_38f9c182c9fd4c8e82b0afe9fe805d7e

Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study

About this item

Full title

Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study

Publisher

England: BioMed Central Ltd

Journal title

Current controlled trials in cardiovascular medicine, 2018-09, Vol.19 (1), p.524-524, Article 524

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Congenital diaphragmatic hernia is an orphan disease with high neonatal mortality and significant morbidity. An important cause for this is pulmonary hypertension, for which no effective postnatal therapy is available to date. An innovative strategy aiming at treating or preventing pulmonary hypertension more effectively is urgently needed. Prenata...

Alternative Titles

Full title

Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_38f9c182c9fd4c8e82b0afe9fe805d7e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_38f9c182c9fd4c8e82b0afe9fe805d7e

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-018-2897-8

How to access this item